**Summary**
Halma plc, a global group of life-saving technology companies, released a trading update on March 12, 2026, ahead of its financial year-end on March 31, 2026. The company reports strong progress in the second half of the financial year, consistent with its upgraded guidance from November 2025. Key highlights include
1. **Financial Performance**
Expected mid-teens percentage organic constant currency revenue growth, driven by premium growth in photonics within the Environmental & Analysis Sector.
Adjusted EBIT margin of around 22% (excluding a one-off profit from the Nuvonic transaction).
Full-year cash conversion in line with the 90% KPI, supporting strategic investments and acquisitions.
2. **Market Conditions**
Varied end-market conditions and economic uncertainties, but broad-based growth across the Group due to its Sustainable Growth Model.
Order intake remains ahead of revenue and the comparable period last year.
3. **Acquisitions**
Completed five acquisitions in the year, totaling a record £451m in investment, with a healthy pipeline across all three sectors (Safety, Environment, Healthcare).
Notable acquisitions include E2S Group Ltd, Safetec Srl, and Altomed.
4. **Currency Impact**
Sterling appreciation is expected to negatively impact revenue by £63m and profit by £14m due to currency translation effects.
5. **Future Outlook**
On track to deliver the 23rd consecutive year of record Adjusted profit.
Full-year results will be released on June 11, 2026.
Halma remains focused on its purpose of growing a safer, cleaner, healthier future, with over 9,000 employees across more than 20 countries and a strong position in the FTSE 100 index.